Moderna Inc announced that it has begun the late-stage trial of potential COVID-19 vaccine mRNA-1273 in the US. The study involves 30,000 healthy adults, which makes it the largest vaccine trial so far. It is also the first Phase-3 trial of a vaccine candidate in the US. The company hopes to deliver results by the end of November.